Chromogranin A, Serum
Method Description Describes how the test is performed and provides a method-specific reference
Chromogranin A (CGA) is measured in a homogeneous automated immunofluorescent assay. This assay uses technology based on a variant of Foerster resonance energy transfer, called time-resolved amplified cryptate emission (TRACE).
A mouse monoclonal antibody against CGA is labeled with europium cryptate (TRACE donor) and a second mouse monoclonal antibody against CGA is labeled with XL665 (TRACE acceptor). CGA is sandwiched between the 2 antibodies, bringing them into close proximity. When the antigen-antibody complex is excited with a nitrogen laser at 337 nm, some fluorescent energy is emitted at 620 nm and the rest is transferred by nonradiative dipole-dipole coupling to XL665. This energy is then emitted as fluorescence at 665 nm. A ratio of the energy emitted at 665 nm to that emitted at 620 nm (internal reference) is calculated for each sample. Signal intensity is proportional to the number of antigen-antibody complexes formed, and therefore to antigen concentration.(Unpublished Mayo method)
PDF Report Indicates whether the report includes an additional document with charts, images or other enriched information
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Same day/1 day
Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location The location of the laboratory that performs the test